CCL14 and acute kidney injury: Our cumulative results showed that CCL14 was not effective in predicting persistent S-AKI without differentiation of severity, as suggested by previous studies that CCL14 was mainly used to predict persistent severe AKI (stages II–III) [21, 22, 29].